News
This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...
Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.
We discovered that FOLR1 was predominantly expressed in epithelial ovarian cancer cells, with similar expression levels observed in both primary ovarian tumors and metastatic omental tumors from ...
When ovarian cancer moves beyond your ovaries or fallopian tubes, cancer cells may reach your liver, lungs, or other places in your body. The stage your doctor assigns to your ovarian cancer can ...
After you’ve gone through ovarian cancer treatment, your doctor will work with you to make sure you stay well. But sometimes the cancer returns. Doctors call this “recurrence.” To check for ...
Friday, Oct. 24, 2014. (AP Photo/Pablo Martinez Monsivais, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] A common blood test may miss ovarian cancer in some Black and ...
Palliative care is not just about medicines to control symptoms. Cancer treatments can also reduce or get rid of symptoms. For example, they can help to reduce pain by shrinking a tumour and reducing ...
Rachael Misfud said Rachael Misfud / SWNS (2) A mom of four said she was put on a nine-month waiting list to remove what was thought to be a benign cyst — but it was ovarian cancer that she ...
A clinician nudge at the time of a suspected ovarian cancer diagnosis improved gynecologic oncology referral rates by 20 percentage points. A randomized controlled trial of this strategy is planned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results